{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:32:01Z","timestamp":1777901521089,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024J011169"],"award-info":[{"award-number":["2024J011169"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04460-z","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:06:15Z","timestamp":1774278375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low GBX2 expression is associated with histological type B thymoma: a multi-omics analysis"],"prefix":"10.1007","volume":"17","author":[{"given":"Zheng","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuxun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"1","key":"4460_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","volume":"44","author":"WK de Jong","year":"2008","unstructured":"de Jong WK, et al. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer. 2008;44(1):123\u201330.","journal-title":"Eur J Cancer"},{"issue":"10","key":"4460_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","volume":"10","author":"A Marx","year":"2015","unstructured":"Marx A, et al. The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J Thorac Oncol. 2015;10(10):1383\u201395.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"4460_CR3","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0022-5223(03)00798-0","volume":"126","author":"K Nakagawa","year":"2003","unstructured":"Nakagawa K, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg. 2003;126(4):1134\u201340.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9 Suppl 2","key":"4460_CR4","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1097\/JTO.0000000000000299","volume":"9","author":"B Weksler","year":"2014","unstructured":"Weksler B, Lu B. Alterations of the immune system in thymic malignancies. J Thorac Oncol. 2014;9(9 Suppl 2):S137\u201342.","journal-title":"J Thorac Oncol"},{"key":"4460_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ctrv.2018.02.004","volume":"65","author":"C Belli","year":"2018","unstructured":"Belli C, et al. Targeting the microenvironment in solid tumors. Cancer Treat Rev. 2018;65:22\u201332.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"4460_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"issue":"3","key":"4460_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"8","key":"4460_CR8","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-15-1849","volume":"22","author":"HM Zarour","year":"2016","unstructured":"Zarour HM. Reversing T-cell dysfunction and exhaustion in cancer. Clin Cancer Res. 2016;22(8):1856\u201364.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4460_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/00001622-200009000-00007","volume":"12","author":"HK M\u00fcller-Hermelink","year":"2000","unstructured":"M\u00fcller-Hermelink HK, Marx A. Thymoma. Curr Opin Oncol. 2000;12(5):426\u201333.","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"4460_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.1017","volume":"50","author":"C Buckley","year":"2001","unstructured":"Buckley C, et al. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in Myasthenia Gravis. Ann Neurol. 2001;50(1):64\u201372.","journal-title":"Ann Neurol"},{"key":"4460_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.962743","volume":"9","author":"V Raufaste-Cazavieille","year":"2022","unstructured":"Raufaste-Cazavieille V, Santiago R, Droit A. Multi-omics analysis: paving the path toward achieving precision medicine in cancer treatment and immuno-oncology. Front Mol Biosci. 2022;9:962743.","journal-title":"Front Mol Biosci"},{"issue":"7","key":"4460_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.14348\/molcells.2021.0042","volume":"44","author":"YJ Heo","year":"2021","unstructured":"Heo YJ, et al. Integrative multi-omics approaches in cancer research: from biological networks to clinical subtypes. Mol Cells. 2021;44(7):433\u201343.","journal-title":"Mol Cells"},{"key":"4460_CR13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.csbj.2021.01.009","volume":"19","author":"O Menyh\u00e1rt","year":"2021","unstructured":"Menyh\u00e1rt O, Gy\u0151rffy B. Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis. Comput Struct Biotechnol J. 2021;19:949\u201360.","journal-title":"Comput Struct Biotechnol J"},{"issue":"2","key":"4460_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","volume":"33","author":"M Radovich","year":"2018","unstructured":"Radovich M, et al. The integrated genomic landscape of thymic epithelial tumors. Cancer Cell. 2018;33(2):244-258.e10.","journal-title":"Cancer Cell"},{"issue":"7","key":"4460_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"key":"4460_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"4460_CR17","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"key":"4460_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, et al. IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol. 2021;12:687975.","journal-title":"Front Immunol"},{"issue":"5","key":"4460_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"4","key":"4460_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/bjc.2015.425","volume":"114","author":"M Radovich","year":"2016","unstructured":"Radovich M, et al. A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas. Br J Cancer. 2016;114(4):477\u201384.","journal-title":"Br J Cancer"},{"key":"4460_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"issue":"7873","key":"4460_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583\u20139.","journal-title":"Nature"},{"issue":"1","key":"4460_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-023-05615-3","volume":"24","author":"C Liao","year":"2023","unstructured":"Liao C, Wang X. TCGAplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data. BMC Bioinformatics. 2023;24(1):483.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"4460_CR24","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/annonc\/mdn388","volume":"19","author":"C Christodoulou","year":"2008","unstructured":"Christodoulou C, et al. Response of malignant thymoma to erlotinib. Ann Oncol. 2008;19(7):1361\u20132.","journal-title":"Ann Oncol"},{"issue":"1","key":"4460_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-017-0655-2","volume":"16","author":"T Bellissimo","year":"2017","unstructured":"Bellissimo T, et al. Thymic epithelial tumors phenotype relies on miR-145-5p epigenetic regulation. Mol Cancer. 2017;16(1):88.","journal-title":"Mol Cancer"},{"issue":"12","key":"4460_CR26","first-page":"2200","volume":"38","author":"E Takahashi","year":"2011","unstructured":"Takahashi E, Koshiishi H, Takahashi M. [A response to erlotinib hydrochloride in the case of post-operative recurrent thymoma]. Gan To Kagaku Ryoho. 2011;38(12):2200\u20131.","journal-title":"Gan To Kagaku Ryoho"},{"key":"4460_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","volume":"99","author":"M Scorsetti","year":"2016","unstructured":"Scorsetti M, et al. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016;99:332\u201350.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"4460_CR28","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1038\/s41467-022-31951-8","volume":"13","author":"Y Yasumizu","year":"2022","unstructured":"Yasumizu Y, et al. Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma. Nat Commun. 2022;13(1):4230.","journal-title":"Nat Commun"},{"issue":"1","key":"4460_CR29","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/s41598-019-38878-z","volume":"9","author":"L Yu","year":"2019","unstructured":"Yu L, et al. Genetic characterization of thymoma. Sci Rep. 2019;9(1):2369.","journal-title":"Sci Rep"},{"issue":"7","key":"4460_CR30","first-page":"1391","volume":"58","author":"AC Gao","year":"1998","unstructured":"Gao AC, Lou W, Isaacs JT. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity. Cancer Res. 1998;58(7):1391\u20134.","journal-title":"Cancer Res"},{"issue":"1","key":"4460_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/15476286.2020.1790140","volume":"18","author":"X Li","year":"2021","unstructured":"Li X, et al. NCBP3\/SNHG6 inhibits GBX2 transcription in a histone modification manner to facilitate the malignant biological behaviour of glioma cells. RNA Biol. 2021;18(1):47\u201363.","journal-title":"RNA Biol"},{"issue":"5","key":"4460_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10142-022-00870-8","volume":"22","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, et al. Oncogenic GBX2 promotes the malignant behaviors of bladder cancer cells by binding to the ITGA5 promoter and activating its transcription. Funct Integr Genomics. 2022;22(5):937\u201350.","journal-title":"Funct Integr Genomics"},{"issue":"7","key":"4460_CR33","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1038\/s41418-020-0502-7","volume":"27","author":"IK Kim","year":"2020","unstructured":"Kim IK, et al. Mutant GTF2I induces cell transformation and metabolic alterations in thymic epithelial cells. Cell Death Differ. 2020;27(7):2263\u201379.","journal-title":"Cell Death Differ"},{"key":"4460_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026534","author":"N Attar","year":"2017","unstructured":"Attar N, Kurdistani SK. Exploitation of EP300 and CREBBP lysine acetyltransferases by cancer. Cold Spring Harb Perspect Med. 2017. https:\/\/doi.org\/10.1101\/cshperspect.a026534.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"4460_CR35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6(1):362.","journal-title":"Signal Transduct Target Ther"},{"key":"4460_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020210","author":"M Haist","year":"2021","unstructured":"Haist M, et al. The functional crosstalk between myeloid-derived suppressor cells and regulatory T Cells within the immunosuppressive tumor microenvironment. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13020210.","journal-title":"Cancers"},{"key":"4460_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147864","author":"C Masaoutis","year":"2022","unstructured":"Masaoutis C, et al. Unraveling the immune microenvironment of thymic epithelial tumors: implications for autoimmunity and treatment. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23147864.","journal-title":"Int J Mol Sci"},{"issue":"7693","key":"4460_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"7","key":"4460_CR39","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/molbev\/msn094","volume":"25","author":"R Zhang","year":"2008","unstructured":"Zhang R, Wang YQ, Su B. Molecular evolution of a primate-specific microRNA family. Mol Biol Evol. 2008;25(7):1493\u2013502.","journal-title":"Mol Biol Evol"},{"issue":"3","key":"4460_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/path.4014","volume":"227","author":"I Flor","year":"2012","unstructured":"Flor I, Bullerdiek J. The dark side of a success story: microRNAs of the C19MC cluster in human tumours. J Pathol. 2012;227(3):270\u20134.","journal-title":"J Pathol"},{"issue":"11","key":"4460_CR41","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton TM, et al. Oxidative phosphorylation as an emerging target in cancer therapy. Clin Cancer Res. 2018;24(11):2482\u201390.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"4460_CR42","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/ijc.29934","volume":"138","author":"K Birkenmeier","year":"2016","unstructured":"Birkenmeier K, et al. Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma are highly dependent on oxidative phosphorylation. Int J Cancer. 2016;138(9):2231\u201346.","journal-title":"Int J Cancer"},{"issue":"23","key":"4460_CR43","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.4161\/cc.10.23.18151","volume":"10","author":"D Whitaker-Menezes","year":"2011","unstructured":"Whitaker-Menezes D, et al. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle. 2011;10(23):4047\u201364.","journal-title":"Cell Cycle"},{"key":"4460_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/path.6496","author":"K Fujikura","year":"2025","unstructured":"Fujikura K, et al. Genome-wide analysis of somatic noncoding mutation patterns and mitochondrial heteroplasmic shift in type B1 and B2 thymomas. J Pathol. 2025. https:\/\/doi.org\/10.1002\/path.6496.","journal-title":"J Pathol"},{"issue":"Pt 5","key":"4460_CR45","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1242\/jcs.118273","volume":"126","author":"CI Tai","year":"2013","unstructured":"Tai CI, Ying QL. Gbx2, a LIF\/Stat3 target, promotes reprogramming to and retention of the pluripotent ground state. J Cell Sci. 2013;126(Pt 5):1093\u20138.","journal-title":"J Cell Sci"},{"issue":"4","key":"4460_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41577-019-0238-0","volume":"20","author":"N Kadouri","year":"2020","unstructured":"Kadouri N, et al. Thymic epithelial cell heterogeneity: TEC by TEC. Nat Rev Immunol. 2020;20(4):239\u201353.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"4460_CR47","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","volume":"19","author":"M Dominguez-Villar","year":"2018","unstructured":"Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. 2018;19(7):665\u201373.","journal-title":"Nat Immunol"},{"issue":"5659","key":"4460_CR48","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1090922","volume":"303","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 2004;303(5659):848\u201351.","journal-title":"Science"},{"issue":"10 Suppl 4","key":"4460_CR49","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.1097\/JTO.0b013e3181f21114","volume":"5","author":"A Rajan","year":"2010","unstructured":"Rajan A, Giaccone G. Targeted therapy for advanced thymic tumors. J Thorac Oncol. 2010;5(10 Suppl 4):S361\u20134.","journal-title":"J Thorac Oncol"},{"key":"4460_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102722","author":"AC Agrafiotis","year":"2023","unstructured":"Agrafiotis AC, et al. Immunotherapy and targeted therapies efficacy in thymic epithelial tumors: a systematic review. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11102722.","journal-title":"Biomedicines"},{"issue":"6","key":"4460_CR51","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1177\/030089160809400613","volume":"94","author":"R Pedersini","year":"2008","unstructured":"Pedersini R, et al. Erlotinib in advanced well-differentiated thymic carcinoma with overexpression of EGFR: a case report. Tumori. 2008;94(6):849\u201352.","journal-title":"Tumori"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04460-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:03:55Z","timestamp":1777633435000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04460-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4460"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04460-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used in the study are derived from a de-identified GEO and TCGA database. As this study utilized secondary research involving de-identified data, it was not considered human participant research and did not require institutional review board approval. Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript. They guarantee that this article is the author's original work and has not been previously published or considered for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"673"}}